The testing company ended last year with $79 million and told investors it will need to raise money to fund its operations ...
The latest unsurprising development in 23andMe’s story is the admission, by their new board of directors, that 23andMe now does not have enough cash to continue for the next 12 months. They are now ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback